迪瑞醫療(300396.SZ):取得1項醫療器械註冊證
格隆匯 12 月 30日丨迪瑞醫療(300396.SZ)公佈,公司於近日取得由國家藥品監督管理局頒發的1項《醫療器械註冊證》,具體情況如下:

化學發光免疫分析是體外診斷行業最重要的細分項目之一,公司佈局化學發光免疫產業多年,目前進入到收穫期,銷售渠道佈局正在逐步完善當中。公司目前發光產品可以進行甲狀腺功能、傳染病、性激素、骨代謝、炎症、腫瘤標誌物、糖代謝、心肌標誌物、腎功能、高血壓、肝纖維化、貧血等項目的檢測。目前,公司化學發光免疫分析儀器相關產品有CM-180、CM-320、CM-320i全自動化學發光免疫分析儀及CSM-8000模塊化生化免疫分析系統,化學發光免疫分析試劑相關產品註冊證擁有約80餘項,是國內體外診斷行業化學發光檢測項目較為齊全的廠家之一。在未來發展中,公司將繼續開發補充臨牀高價值檢驗項目,持續豐富體外診斷產品覆蓋領域,助力公司快速發展。
上述《醫療器械註冊證》的取得,豐富了公司產品種類,將進一步增強公司綜合競爭力,有利於進一步提高公司的市場拓展能力,對公司未來的經營將產生積極影響。上述產品實際銷售情況取決於未來市場推廣效果,公司目前尚無法預測其對公司未來業績的影響,敬請投資者注意投資風險。公司未來會積極推動相關產品在國內市場的銷售,為廣大股東創造更大的價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.